Back
Nuvation Bio, Inc. 10K Form
Sell
40
NUVB
Nuvation Bio, Inc.
Last Price:
$4.42
Seasonality Move:
8.74%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2021-05-21 | 10K | NUVB/Nuvation Bio, Inc. Annual |
| 2021-05-17 | 10Q | NUVB/Nuvation Bio, Inc. Quarterly |
| 2021-03-11 | 10K | NUVB/Nuvation Bio, Inc. Annual |
| 2020-11-16 | 10Q | NUVB/Nuvation Bio, Inc. Quarterly |
| 2020-08-14 | 10Q | NUVB/Nuvation Bio, Inc. Quarterly |
Receive NUVB News And Ratings
See the #1 stock for the next 7 days that we like better than NUVB
NUVB Financial Statistics
Sales & Book Value
| Annual Sales: | $62.9M |
|---|---|
| Cash Flow: | $-29.8M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.90 |
| Price / Book: | 4.91 |
Profitability
| EPS (TTM): | -0.59970 |
|---|---|
| Net Income (TTM): | $-204.6M |
| Gross Margin: | $51.9M |
| Return on Equity: | -54.2% |
| Return on Assets: | -35.57% |
Nuvation Bio, Inc. Earnings Forecast
Key Nuvation Bio, Inc. Financial Ratios
-
The Gross Profit Margin over the past 6 years for NUVB is 82.45%.
-
The Selling, General & Administrative Expenses for NUVB have been equal to 240.95% of Gross Profit Margin.
-
The Research & Development expenses have been 182.99% of Revenue.
-
The Net Earning history of NUVB is -325.31% of Total Revenues.
-
Per Share Earnings over the last 6 years have been positive in 2 years.
Nuvation Bio, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | NUVB |
| Website: | nuvationbio.com |
Debt
| Debt-to-Equity Ratio: | 0.7 |
|---|---|
| Current Ratio: | 6.95 |
| Quick Ratio: | 6.63 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 54.4 |
NUVB Technical Analysis vs Fundamental Analysis
Sell
40
Nuvation Bio, Inc. (NUVB)
is a Sell
Is Nuvation Bio, Inc. a Buy or a Sell?
-
Nuvation Bio, Inc. stock is rated a SellThe current Nuvation Bio, Inc. [NUVB] share price is $4.41. The Score for NUVB is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.